Higher NT-proBNP levels and the risk of intradialytic hypotension at hemodialysis initiation

被引:4
作者
Curtis, Katherine A. [1 ,2 ,3 ]
Waikar, Sushrut S. [4 ]
Mc Causland, Finnian R. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Renal Med, 45 Francis St,Med Res Bldg,Suite 416, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA
[4] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA USA
关键词
hemodialysis; hypervolemia; hypotension; NT-proBNP; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR MORBIDITY; MORTALITY RISK; ASSOCIATION; DIALYSIS; DEFINITIONS; PREDICTORS; OVERLOAD; ESRD;
D O I
10.1111/hdi.13125
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Elevated N-terminal pro B-type natriuretic peptide (NT-proBNP) is a potent predictor of adverse outcomes in hemodialysis initiation. These patients often experience intradialytic hypotension, which may partially reflect cardiac dysfunction, but the association of NT-proBNP with intradialytic hypotension is not clear.Methods: We performed a post hoc analysis of a randomized trial that tested mannitol versus placebo in 52 patients initiating hemodialysis (NCT01520207). NT-proBNP was measured prior to the first and third sessions (n = 87). Mixed-effects models (adjusting for randomized treatment, sex, race, age, diabetes, heart failure, catheter use, pre-dialysis systolic blood pressure, pre-dialysis weight, ultrafiltration volume, serum sodium, bicarbonate, urea nitrogen, phosphate, albumin, hemoglobin, and session length) were fit to examine the association of NT-proBNP with systolic blood pressure decline (pre-dialysis minus nadir systolic blood pressure). Additionally, mixed-effects Poisson models were fit to examine the association with intradialytic hypotension (>= 20 mmHg decline in systolic blood pressure).Findings: Mean age was 55 +/- 16 years; 33% had baseline heart failure. The median NT-proBNP was 5498 [25th-75th percentile 2011, 14,790] pg/mL; 26 sessions (30%) were complicated by intradialytic hypotension. In adjusted models, each unit higher log-NT-proBNP was associated with 6.0 mmHg less decline in systolic blood pressure (95%CI -9.2 to -2.8). Higher pre-dialysis NT-proBNP, per log-unit, was associated with a 52% lower risk of intradialytic hypotension (IRR 0.48, 95%CI 0.23-0.97), without evidence for effect modification by randomized treatment (P-interaction = 0.17).Discussion: In patients initiating hemodialysis, higher NT-proBNP is associated with less decline in intradialytic systolic blood pressure and lower risk of intradialytic hypotension. Future studies should investigate if higher pre-dialysis NT-proBNP levels may identify patients who might tolerate more aggressive ultrafiltration.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [41] NT-proBNP as a means of triage for the risk of hospitalisation in primary care
    Adlbrecht, Christopher
    Neuhold, Stephanie
    Huelsmann, Martin
    Strunk, Guido
    Ehmsen, Udo
    Scholten, Christine
    Maurer, Gerald
    Pacher, Richard
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (01) : 55 - 61
  • [42] The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention
    Ayhan, Erkan
    Isik, Turgay
    Uyarel, Huseyin
    Ergelen, Mehmet
    Cicek, Gokhan
    Ozyurtlu, Ferhat
    Ghannadian, Bahman
    Tanboga, Ibrahim Halil
    KARDIOLOGIA POLSKA, 2013, 71 (02) : 165 - 175
  • [43] Influence of pneumoperitoneum on left ventricular filling pressures and NT-proBNP levels
    Russo, A.
    Di Stasio, E.
    Scagliusi, A.
    Bevilacqua, F.
    Scarano, A. M.
    Marana, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (11) : 1570 - 1575
  • [44] NT-proBNP levels in systemic sclerosis: Association with clinical and laboratory abnormalities
    Oravec, Rejane Maria
    Bredemeier, Markus
    Laurino, Claudia Cilene
    Furlan Pinotti, Antonio Fernando
    Paim Rohde, Luis Eduardo
    Tavares Brenol, Joao Carlos
    Xavier, Ricardo Machado
    CLINICAL BIOCHEMISTRY, 2010, 43 (09) : 745 - 749
  • [45] NT-proBNP levels and hypertension.: Their importance in the diagnosis of heart failure
    Rivera, M
    Talèns-Visconti, R
    Salvador, A
    Bertomeu, V
    Miró, V
    de Burgos, FG
    Climent, V
    Cortés, R
    Payá, R
    Pérez-Boscá, JL
    Mainar, L
    Jordán, A
    Sogorb, F
    Cosín, J
    Mora, V
    Diago, JL
    Marín, F
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (05): : 396 - 402
  • [46] Circulating trans fatty acids are related to serum levels of NT-proBNP in general population
    Wang, Xiaoqian
    Chen, Xiaotian
    Jiang, Fengjuan
    Cheng, Yongqing
    Li, Yuan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 422
  • [47] TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy
    Hernandez-Romero, Diana
    Jover, Eva
    Martinez, Carlos M.
    Andreu-Cayuelas, Jose M.
    Orenes-Pinero, Esteban
    Romero-Aniorte, Ana I.
    Casas, Teresa
    Canovas, Sergio
    Montero-Argudo, Jose A.
    Valdes, Mariano
    de la Morena, Gonzalo
    Marin, Francisco
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (02) : 179 - 186
  • [48] THE VOLUME LOAD OF HEMODIALYSIS PATIENTS WITH END-STAGE RENAL DISEASE AND THE CLINICAL VALUE OF NT-PROBNP
    Zhou, Huahong
    Dong, Yi
    Cheng, Dong
    Zhang, Ting
    Lang, Xujun
    Yang, Zhihao
    Fu, Xiaojun
    ACTA MEDICA MEDITERRANEA, 2021, 37 (04): : 2069 - 2073
  • [49] Relation between NT-proBNP Levels, Iron Overload, and Early Stage of Myocardial Dysfunction in ß-Thalassemia Major Patients
    Balkan, Can
    Tuluce, Selcen Yakar
    Basol, Gunes
    Tuluce, Kamil
    Ay, Yilmaz
    Karapinar, Deniz Yilmaz
    Gurgun, Cemil
    Bayindir, Oya
    Kavakli, Kaan
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (03): : 318 - 325
  • [50] Clinical utility of NT-proBNP levels in late heart transplantation patients
    Avello, Noelia
    Prieto, Belen
    Molina, Beatriz D.
    Rodriguez-Lambert, Jose L.
    Alvarez, Francisco V.
    CLINICA CHIMICA ACTA, 2010, 411 (3-4) : 161 - 166